UK-based P2i Limited, a nanoscale enhancer of products using its proprietary cold plasma deposition technology, has appointed Dr Graham Hine as chairman of the board of directors with immediate effect.  

Dr Hine has a successful background in advanced electronic materials, semiconductors and sensors. After gaining a degree and PhD in Physics at Cambridge University, Dr Hine’s career began in the semiconductor division at Philips where he moved through technology development into international sales and marketing. From Philips, he went on to hold a number of senior business development and general management roles before becoming CEO of Capteur Sensors Ltd.

P2i Ltd. was established in 2004 to commercialise super liquid-repellent treatments developed by the Defence Science and Technology Laboratory (Dstl) and the University of Durham. P2i is the exclusive licensee of Dstl’s patents and is a joint venture between Dstl and Porton Capital. P2i’s plasma technology enables it to deposit materials in layers only nanometres thick over the whole surface of a product by means of an ionised gas or plasma”. This enables the surfaces of the product to be enhanced with a super oleophobic (oil repellent) and hydrophobic (water-repellent) treatment while leaving the other properties of the product unchanged.  Now on a commercial scale, P2i’s enhancement process can be applied to a wide range of products in the textiles, medical, pharmaceutical, electronics and homeland security markets.